Disturbed balance between phase I and II metabolizing enzymes in ovarian endometriosis: A source of excessive hydroxy-estrogens and ROS?

Molecular and Cellular Endocrinology

Volumn 367, Issue 1-2, 2013, Pages 74-84

  Hevir, Neli ^a   Ribič Pucelj, Martina ^b   Lanišnik Rižner, Tea ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

(NRH):quinone oxidoreductase 2 (NQO2); Catechol O methyltransferase (COMT); Cytochrome P450 (CYP); Glutathione S transferase pi 1 (GSTP1); NAD(P)H:quinone oxidoreductase 1 (NQO1); Sulfotransferases (SULTs)

Indexed keywords

ESTROGEN;

ADULT; AEROBIC METABOLISM; ARTICLE; CELL PROLIFERATION; COMT GENE; CONTROLLED STUDY; CYP1A1 GENE; CYP1B1 GENE; CYP3A7 GENE; ENDOMETRIOSIS; ENZYME METABOLISM; FEMALE; GENE; GENE EXPRESSION; GSTP1 GENE; HORMONE METABOLISM; HUMAN; IMMUNOHISTOCHEMISTRY; MENSTRUAL CYCLE; NQO1 GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SULT1A1 GENE; UPREGULATION; WESTERN BLOTTING;

ADULT; ARYL HYDROCARBON HYDROXYLASES; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CATECHOL O-METHYLTRANSFERASE; CYTOCHROME P-450 CYP1A1; ENDOMETRIOSIS; ESTROGENS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUTATHIONE S-TRANSFERASE PI; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; METABOLIC DETOXICATION, PHASE I; METABOLIC DETOXICATION, PHASE II; NAD(P)H DEHYDROGENASE (QUINONE); OVARY; REACTIVE OXYGEN SPECIES; STEROID 16-ALPHA-HYDROXYLASE; STEROID HYDROXYLASES; UP-REGULATION; YOUNG ADULT;

EID: 84873525942     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2012.12.019     Document Type: Article

References (47)

1. Adjei A.A., Weinshilboum R.M. Catecholestrogen sulfation: possible role in carcinogenesis. Biochem. Biophys. Res. Commun. 2002, 292:402-408.
2. Agarwal A., Gupta S., Sharma R.K. Role of oxidative stress in female reproduction. Reprod. Biol. Endocrinol. 2005, 3:28.
3. Al-Gubory K.H., Fowler P.A., Garrel C. The roles of cellular reactive oxygen species, oxidative stress and antioxidants in pregnancy outcomes. Int. J. Biochem. Cell Biol. 2010, 42:1634-1650.
4. Bai H.W., Shim J.Y., Yu J., Zhu B.T. Biochemical and molecular modeling studies of the O-methylation of various endogenous and exogenous catechol substrates catalyzed by recombinant human soluble and membrane-bound catechol-O-methyltransferases. Chem. Res. Toxicol. 2007, 20:1409-1425.
5. Baldi A., Campioni M., Signorile P.G. Endometriosis: pathogenesis, diagnosis, therapy and association with cancer (review). Oncol. Rep. 2008, 19:843-846.
6. Berkley K.J., Rapkin A.J., Papka R.E. The pains of endometriosis. Science 2005, 308:1587-1589.
7. Bulun S.E. Endometriosis. N. Engl. J. Med. 2009, 360:268-279.
8. Cavalieri E., Chakravarti D., Guttenplan J., Hart E., Ingle J., Jankowiak R., Muti P., Rogan E., Russo J., Santen R., Sutter T. Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention. Biochim. Biophys. Acta 2006, 1766:63-78.
9. Chun Y.J., Kim S. Discovery of cytochrome P450 1B1 inhibitors as new promising anti-cancer agents. Med. Res. Rev. 2003, 23:657-668.
10. Gaikwad N.W., Rogan E.G., Cavalieri E.L. Evidence from ESI-MS for NQO1-catalyzed reduction of estrogen ortho-quinones. Free Radic. Biol. Med. 2007, 43:1289-1298.
11. Gaikwad N.W., Yang L., Rogan E.G., Cavalieri E.L. Evidence for NQO2-mediated reduction of the carcinogenic estrogen ortho-quinones. Free Radic. Biol. Med. 2009, 46:253-262.
12. Giudice L.C., Kao L.C. Endometriosis. Lancet 2004, 364:1789-1799.
13. Guillemette C., Belanger A., Lepine J. Metabolic inactivation of estrogens in breast tissue by UDP-glucuronosyltransferase enzymes: an overview. Breast Cancer Res. 2004, 6:246-254.
14. Gupta M., McDougal A., Safe S. Estrogenic and antiestrogenic activities of 16alpha- and 2-hydroxy metabolites of 17beta-estradiol in MCF-7 and T47D human breast cancer cells. J. Steroid Biochem. Mol. Biol. 1998, 67:413-419.
15. Hachey D.L., Dawling S., Roodi N., Parl F.F. Sequential action of phase I and II enzymes cytochrome p450 1B1 and glutathione S-transferase P1 in mammary estrogen metabolism. Cancer Res. 2003, 63:8492-8499.
16. Hevir N., Vouk K., Šinkovec J., Ribič-Pucelj M., LaniŠnik RiŽner T. Aldo-keto reductases AKR1C1, AKR1C2 and AKR1C3 may enhance progesterone metabolism in ovarian endometriosis. Chem. Biol. Interact. 2011, 191:217-226.
17. Hirata H., Hinoda Y., Okayama N., Suehiro Y., Kawamoto K., Kikuno N., Rabban J.T., Chen L.M., Dahiya R. CYP1A1, SULT1A1, and SULT1E1 polymorphisms are risk factors for endometrial cancer susceptibility. Cancer 2008, 112:1964-1973.
18. Hompes P.G., Mijatovic V. Endometriosis: the way forward. Gynecol. Endocrinol. 2007, 23:5-12.
19. Huang Z., Guengerich F.P., Kaminsky L.S. 16Alpha-hydroxylation of estrone by human cytochrome P4503A4/5. Carcinogenesis 1998, 19:867-872.
20. Huber J.C., Ott J. The dialectic role of progesterone. Maturitas 2009, 62:326-329.
21. Igarashi T., Osuga U., Tsutsumi O., Momoeda M., Ando K., Matsumi H., Takai Y., Okagaki R., Hiroi H., Fujiwara O., Yano T., Taketani Y. Expression of Ah receptor and dioxin-related genes in human uterine endometrium in women with or without endometriosis. Endocr. J. 1999, 46:765-772.
22. Jaiswal A.K. Regulation of genes encoding NAD(P)H:quinone oxidoreductases. Free Radic. Biol. Med. 2000, 29:254-262.
23. Jaiswal A.K., McBride O.W., Adesnik M., Nebert D.W. Human dioxin-inducible cytosolic NAD(P)H:menadione oxidoreductase. cDNA sequence and localization of gene to chromosome 16. J. Biol. Chem. 1988, 263:13572-13578.
24. Jefcoate C.R., Liehr J.G., Santen R.J., Sutter T.R., Yager J.D., Yue W., Santner S.J., Tekmal R., Demers L., Pauley R., Naftolin F., Mor G., Berstein L. Tissue-specific synthesis and oxidative metabolism of estrogens. J. Natl. Cancer Inst. Monogr. 2000, 95-112.
25. LaniŠnik RiŽner T. Estrogen metabolism and action in endometriosis. Mol. Cell Endocrinol. 2009, 307:8-18.
26. Lee A.J., Cai M.X., Thomas P.E., Conney A.H., Zhu B.T. Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms. Endocrinology 2003, 144:3382-3398.
27. Lepine J., Bernard O., Plante M., Tetu B., Pelletier G., Labrie F., Belanger A., Guillemette C. Specificity and regioselectivity of the conjugation of estradiol, estrone, and their catecholestrogen and methoxyestrogen metabolites by human uridine diphospho-glucuronosyltransferases expressed in endometrium. J. Clin. Endocrinol. Metab. 2004, 89:5222-5232.
28. Long D.J., Jaiswal A.K. NRH:quinone oxidoreductase2 (NQO2). Chem. Biol. Interact. 2000, 129:99-112.
29. Mier-Cabrera J., Aburto-Soto T., Burrola-Mendez S., Jimenez-Zamudio L., Tolentino M.C., Casanueva E., Hernandez-Guerrero C. Women with endometriosis improved their peripheral antioxidant markers after the application of a high antioxidant diet. Reprod. Biol. Endocrinol. 2009, 7:54.
30. Nap A.W., Groothuis P.G., Demir A.Y., Evers J.L., Dunselman G.A. Pathogenesis of endometriosis. Best Pract. Res. Clin. Obstet. Gynaecol. 2004, 18:233-244.
31. Ngo C., Chereau C., Nicco C., Weill B., Chapron C., Batteux F. Reactive oxygen species controls endometriosis progression. Am. J. Pathol. 2009, 175:225-234.
32. Nioi P., Hayes J.D. Contribution of NAD(P)H:quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors. Mutat. Res. 2004, 555:149-171.
33. Pasqualini J.R., Chetrite G.S. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer. J. Steroid Biochem. Mol. Biol. 2005, 93:221-236.
34. Pihlavisto P., Reenila I. Separation methods for catechol O-methyltransferase activity assay: physiological and pathophysiological relevance. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2002, 781:359-372.
35. Raftogianis R., Creveling C., Weinshilboum R., Weisz J. Estrogen metabolism by conjugation. J. Natl. Cancer Inst. Monogr. 2000, 113-124. (Chapter 6).
36. Salama S.A., Kamel M., Awad M., Nasser A.H., Al-Hendy A., Botting S., Arrastia C. Catecholestrogens induce oxidative stress and malignant transformation in human endometrial glandular cells: protective effect of catechol-O-methyltransferase. Int. J. Cancer 2008, 123:1246-1254.
37. Singh M.N., Stringfellow H.F., Taylor S.E., Ashton K.M., Ahmad M., Abdo K.R., El-Agnaf O.M., Martin-Hirsch P.L., Martin F.L. Elevated expression of CYP1A1 and gamma-SYNUCLEIN in human ectopic (ovarian) endometriosis compared with eutopic endometrium. Mol. Hum. Reprod. 2008, 14:655-663.
38. Swaneck G.E., Fishman J. Covalent binding of the endogenous estrogen 16 alpha-hydroxyestrone to estradiol receptor in human breast cancer cells: characterization and intranuclear localization. Proc. Natl. Acad. Sci. USA 1988, 85:7831-7835.
39. Tenhunen J., Salminen M., Lundstrom K., Kiviluoto T., Savolainen R., Ulmanen I. Genomic organization of the human catechol O-methyltransferase gene and its expression from two distinct promoters. Eur. J. Biochem. 1994, 223:1049-1059.
40. Terrier P., Townsend A.J., Coindre J.M., Triche T.J., Cowan K.H. An immunohistochemical study of pi class glutathione S-transferase expression in normal human tissue. Am. J. Pathol. 1990, 137:845-853.
41. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3. (RESEARCH0034).
42. Vouk K., Šmuc T., Guggenberger C., Ribic-Pucelj M., Šinkovec J., Husen B., Thole H., Houba P., Thaete C., Adamski J., LaniŠnik Rizner T. Novel estrogen-related genes and potential biomarkers of ovarian endometriosis identified by differential expression analysis. J. Steroid. Biochem. Mol. Biol. 2011, 125:231-242.
43. Watanabe N., Dickinson D.A., Liu R.M., Forman H.J. Quinones and glutathione metabolism. Methods Enzymol. 2004, 378:319-340.
44. Winski S.L., Faig M., Bianchet M.A., Siegel D., Swann E., Fung K., Duncan M.W., Moody C.J., Amzel L.M., Ross D. Characterization of a mechanism-based inhibitor of NAD(P)H:quinone oxidoreductase 1 by biochemical, X-ray crystallographic, and mass spectrometric approaches. Biochemistry 2001, 40:15135-15142.
45. Yager J.D. Endogenous estrogens as carcinogens through metabolic activation. J. Natl. Cancer Inst. Monogr. 2000, 67-73.
46. Zhu B.T., Conney A.H. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 1998, 19:1-27.
47. Zhu B.T., Lee A.J. NADPH-dependent metabolism of 17beta-estradiol and estrone to polar and nonpolar metabolites by human tissues and cytochrome P450 isoforms. Steroids 2005, 70:225-244.